Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Athenex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 10
Athenex Inc, Medical Devices Deals, 2011 to YTD 2017 12
Athenex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
Athenex Inc, Pharmaceuticals & Healthcare, Deal Details 15
Asset Purchase 15
Athenex Acquires 14 ANDAs and Inventory for Certain APIs from Amphastar Pharma 15
Venture Financing 16
Athenex Raises USD20 Million in Venture Debt Financing 16
Athenex Raises USD38 Million in Financing 17
Kinex Pharma Raises USD10 Million in Venture Financing 18
Kinex Pharma Raises USD74.4 Million in Venture Financing 19
Kinex Pharma Raises US$0.3 Million In Venture Financing 20
QuaDPharma Raises US$1 Million In Venture Financing 21
Kinex Pharma Raises Funds In First Tranche Of Financing Round 22
Kinex Pharma Raises US$5 Million In Venture Financing 23
Partnerships 24
Athenex Enters into Agreement with Imuna Pharm 24
Athenex Enters into Partnership with Eli Lilly and Company 25
Athenex to Form Joint Venture with SunGen Pharma 26
Licensing Agreements 27
Almirall to Enter into Licensing Agreement with Athenex for KX2-391 27
Athenex to Enter into Licensing Agreement with Gland Pharma 28
Athenex to Enter into Licensing Agreement with Gland Pharma 29
Kinex Pharma Enters into Licensing Agreement with Hong Kong Polytechnic University and McGill University 30
PharmaEssentia Amends its Licensing Agreement with Athenex for Oraxol and Oratecan 31
Zenith Technology Enters into Licensing Agreement with Kinex Pharma for Oraxol and Oratecan 32
Xiangxue Pharma Enters into Licensing Agreement with Kinex Pharma for KX02 33
Kinex Pharma Expands Licensing Agreement with Hanmi Pharma for Orascovery Program 34
PharmaEssentia Amends its Licensing Agreement with Kinex Pharma 35
Hanmi Pharma Enters into Licensing Agreement with Kinex Pharma for KX01 37
Kinex Pharma Expands Licensing Agreement With Hanmi Pharma 38
Kinex Pharma Enters Into Licensing Agreement With Hanmi Pharma 40
Equity Offering 42
Athenex Raises USD76 Million in IPO 42
Athenex Raises USD3.5 Million in Private Placement of Shares 44
Athenex Raises USD5 Million in Private Placement of Shares 45
Athenex Raises USD6.6 Million in Private Placement of Shares 46
Kinex Pharma Raises Funds through Private Placement of Shares 47
Athenex Raises USD4 Million in Private Placement of Shares 48
Athenex Raises USD6 Million in Private Placement of Series A Preferred Stock 49
Kinex Pharma Completes Private Placement Of Shares For US$40 Million 50
Acquisition 51
Athenex Acquires Comprehensive Drug Enterprises for USD15 Million 51
Athenex Acquires Polymed Therapeutics 52
Kinex Pharma Acquires QuaDPharma for USD5.5 Million 53
Athenex Inc – Key Competitors 54
Athenex Inc – Key Employees 55
Athenex Inc – Locations And Subsidiaries 56
Head Office 56
Other Locations & Subsidiaries 56
Recent Developments 57
Strategy And Business Planning 57
Feb 11, 2016: Governor Cuomo Announces Major Expansion of Athenex — Creating 1,400 Jobs in Western New York 57
Financial Announcements 60
Nov 09, 2017: Athenex Announces Third Quarter 2017 Results 60
Aug 14, 2017: Athenex Announces Second Quarter 2017 Results 63
Corporate Communications 66
Dec 01, 2017: Athenex Announces Planned Retirement of Chief Financial Officer Nick Riehle 66
Mar 01, 2017: Athenex announces the promotion of Jeffrey M. Yordon to the position of Chief Operating Officer 67
Feb 27, 2017: Athenex appoints veteran J. Nick Riehle as Chief Financial Officer 68
Feb 09, 2016: Athenex Announces the Addition of Simon Pedder, PhD and Raymond Yeung, MSc, MBA to its Global Leadership Team 69
Government and Public Interest 70
Sep 11, 2017: Athenex Announces Grant Disbursement Agreement with New York State for Dunkirk Facility 70
Product News 71
Aug 01, 2017: Athenex Announces Recent Product Launches in Commercial Business 71
Clinical Trials 72
Nov 28, 2017: Athenex Announces Acceptance of Phase II Data of KX2-391 for the Treatment of Actinic Keratosis for Presentation at the American Academy of Dermatology Meeting 72
Sep 25, 2017: Athenex Announces First Patient Recruitment in Phase III Clinical Trials for KX-01 Ointment for Actinic Keratosis 73
Mar 28, 2017: Athenex Announces the US FDA Allowance of the Investigational New Drug Application of Oratopo, A Combination of HM30181A and Oral Topotecan For the Treatment of Advanced Cancer 74
Appendix 75
Methodology 75
About GlobalData 75
Contact Us 75
Disclaimer 75
Athenex Inc, Pharmaceuticals & Healthcare, Key Facts 2
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 7
Athenex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 8
Athenex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 9
Athenex Inc, Deals By Therapy Area, 2011 to YTD 2017 10
Athenex Inc, Medical Devices Deals, 2011 to YTD 2017 12
Athenex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 13
Athenex Acquires 14 ANDAs and Inventory for Certain APIs from Amphastar Pharma 15
Athenex Raises USD20 Million in Venture Debt Financing 16
Athenex Raises USD38 Million in Financing 17
Kinex Pharma Raises USD10 Million in Venture Financing 18
Kinex Pharma Raises USD74.4 Million in Venture Financing 19
Kinex Pharma Raises US$0.3 Million In Venture Financing 20
QuaDPharma Raises US$1 Million In Venture Financing 21
Kinex Pharma Raises Funds In First Tranche Of Financing Round 22
Kinex Pharma Raises US$5 Million In Venture Financing 23
Athenex Enters into Agreement with Imuna Pharm 24
Athenex Enters into Partnership with Eli Lilly and Company 25
Athenex to Form Joint Venture with SunGen Pharma 26
Almirall to Enter into Licensing Agreement with Athenex for KX2-391 27
Athenex to Enter into Licensing Agreement with Gland Pharma 28
Athenex to Enter into Licensing Agreement with Gland Pharma 29
Kinex Pharma Enters into Licensing Agreement with Hong Kong Polytechnic University and McGill University 30
PharmaEssentia Amends its Licensing Agreement with Athenex for Oraxol and Oratecan 31
Zenith Technology Enters into Licensing Agreement with Kinex Pharma for Oraxol and Oratecan 32
Xiangxue Pharma Enters into Licensing Agreement with Kinex Pharma for KX02 33
Kinex Pharma Expands Licensing Agreement with Hanmi Pharma for Orascovery Program 34
PharmaEssentia Amends its Licensing Agreement with Kinex Pharma 35
Hanmi Pharma Enters into Licensing Agreement with Kinex Pharma for KX01 37
Kinex Pharma Expands Licensing Agreement With Hanmi Pharma 38
Kinex Pharma Enters Into Licensing Agreement With Hanmi Pharma 40
Athenex Raises USD76 Million in IPO 42
Athenex Raises USD3.5 Million in Private Placement of Shares 44
Athenex Raises USD5 Million in Private Placement of Shares 45
Athenex Raises USD6.6 Million in Private Placement of Shares 46
Kinex Pharma Raises Funds through Private Placement of Shares 47
Athenex Raises USD4 Million in Private Placement of Shares 48
Athenex Raises USD6 Million in Private Placement of Series A Preferred Stock 49
Kinex Pharma Completes Private Placement Of Shares For US$40 Million 50
Athenex Acquires Comprehensive Drug Enterprises for USD15 Million 51
Athenex Acquires Polymed Therapeutics 52
Kinex Pharma Acquires QuaDPharma for USD5.5 Million 53
Athenex Inc, Key Competitors 54
Athenex Inc, Key Employees 55
Athenex Inc, Subsidiaries 56